And there were also 4 pathways correlated with low expression of TARDBP, including fatty acid metabolism, drug metabolism cytochrome p450, retinol metabolism and complement and coagulation cascades, which were also found to be involved in the progress of HCC [27–30]. This evidence concerns the gene TARDBP and hepatocellular carcinoma.